table 1.
study subject demographics
Supplementation regimen and compliance
Each subject received 500 mg of CAPROS (Natreon, Inc., New Brunswick, NJ, USA) supplement b.i.d for 12 weeks. Compliance was monitored by requesting the subjects to return the unfinished or empty bottles to exchange for new ones. Participant supplementation compliance was 83%. Subjects with less than 70% compliance or self-reported noncompliance were excluded from the study.